- Home
- PRTA vs DXYZ Comparison
PRTA vs DXYZ Comparison
Compare PRTA & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- DXYZ
- Stock Information
- Founded
- PRTA 2012
- DXYZ N/A
- Country
- PRTA Ireland
- DXYZ
- Employees
- PRTA N/A
- DXYZ N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- DXYZ
- Sector
- PRTA Health Care
- DXYZ
- Exchange
- PRTA Nasdaq
- DXYZ Nasdaq
- Market Cap
- PRTA 643.0M
- DXYZ 640.4M
- IPO Year
- PRTA N/A
- DXYZ 2024
- Fundamental
- Price
- PRTA $13.77
- DXYZ $56.33
- Analyst Decision
- PRTA Buy
- DXYZ
- Analyst Count
- PRTA 7
- DXYZ 0
- Target Price
- PRTA $46.50
- DXYZ N/A
- AVG Volume (30 Days)
- PRTA 711.1K
- DXYZ N/A
- Earning Date
- PRTA 02-13-2025
- DXYZ N/A
- Dividend Yield
- PRTA N/A
- DXYZ N/A
- EPS Growth
- PRTA N/A
- DXYZ N/A
- EPS
- PRTA N/A
- DXYZ N/A
- Revenue
- PRTA $133,350,000.00
- DXYZ N/A
- Revenue This Year
- PRTA $56.89
- DXYZ N/A
- Revenue Next Year
- PRTA N/A
- DXYZ N/A
- P/E Ratio
- PRTA N/A
- DXYZ N/A
- Revenue Growth
- PRTA N/A
- DXYZ N/A
- 52 Week Low
- PRTA $11.70
- DXYZ N/A
- 52 Week High
- PRTA $34.75
- DXYZ N/A
- Technical
- Relative Strength Index (RSI)
- PRTA 48.19
- DXYZ N/A
- Support Level
- PRTA $12.39
- DXYZ N/A
- Resistance Level
- PRTA $13.64
- DXYZ N/A
- Average True Range (ATR)
- PRTA 1.03
- DXYZ 0.00
- MACD
- PRTA -0.02
- DXYZ 0.00
- Stochastic Oscillator
- PRTA 40.47
- DXYZ 0.00
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About DXYZ Destiny Tech100 Inc. Common Stock
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.